GRC NPC – Hildesheim, Allan
Allan Hildesheim (National Cancer Institute, NIH, USA) “Use of Viral and Genetic Markers for Risk Stratification for Development of Screening Programs for the Early Detection of NPC” 1987 Use of viral and genetic markers for NPC risk stratification. 16% cancers are caused by infectious agents (Lancet Oncol 2012, de Martel) EBV vaccination: EBV gp350 (Coghill et […]
GRC NPC – Hildesheim, Allan Read More »